CM
COMPASS Pathways plc
CMPS · NASDAQ
$14.35 +1.56% (+$0.22)
1M +6.69%
Market Cap $1.92B
P/E Ratio -
Div. Yield -
ROE 398.21%
Bulios Fair Price
$11.86
17.4% downside
Current Price
$14.35
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CMPS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 22.70x
P/E N/A
EV/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 129.74%
Asset turnover 0.00x
ROE 398.21%
Debt
47 /100
Moderate Debt/Equity 0.65x
Int. coverage -75.59x
Current ratio 1.30x
Stability
40 /100
Moderate Beta 2.53x
Profitable years 0
EPS volatility 18.17%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CMPS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Kabir Kumar Nath
Employees
156
Headquarters
London
Upcoming events
03 NOV
Earnings
Upcoming earnings report